GSA Picks Clark to Build Consolidated FDA Facility

September 22, 2010

GSA Picks Clark to Build Consolidated FDA Facility

BETHESDA, Md. – The General Services Administration (GSA) has selected Clark Construction Group, LLC to build the U.S. Food and Drug Administration's (FDA) Consolidated Center for Biologics Evaluation & Research (CBER) in White Oak, Md. Clark was awarded a $202 million contract for two laboratory buildings totaling 533,890 square feet and a 334,000 square-foot supporting office building. Options could add to the scope of work, including constructing an additional supporting office building and an 878,000 square-foot garage. With these options, the full value of the contract could reach $324 million. 

The concrete laboratory buildings will have a glass-and-metal-panel exterior and the office buildings will be a concrete structure with a brick facade. A large skylight creates a central atrium to connect the buildings. The scope of work also includes extensive landscaping of several courtyards on the premises. 

The FDA CBER project will consolidate several local area facilities onto the FDA's campus in White Oak, Md. Clark completed the FDA's Center for Drug Evaluation and Research 2 project at the White Oak campus in 2008. 

Work on the project has already begun and will follow a 40-month construction schedule.